As global demand for smoke-free nicotine alternatives accelerates, procurement professionals and brand owners are increasingly evaluating contract manufacturing partners for nicotine oral strip and film products. SENO, a manufacturer based in Shenzhen, China, backed by Xin Sino Technology (Shenzhen) Co., Ltd., offers a dedicated production platform for nicotine oral thin films with full OEM, ODM, and Private Label capabilities.

Problem / Opportunity

The shift from combustible tobacco to discreet, fast-dissolving nicotine delivery systems has opened a window for private-label brands and distributors. However, selecting a supply partner that can consistently meet regulatory, quality, and customization demands remains a critical challenge. Buyers require a manufacturer with proven export experience, documented compliance, and the production scalability to support multi-region launches.

Brand Solution: SENO’s OEM/ODM Platform

SENO provides OEM, ODM, and Private Label production services for nicotine oral films. Customization options include nicotine strength (2 mg, 4 mg, 6 mg, or custom), flavor development (mint, fruit, and custom profiles), film size and format, packaging design (sachets, retail boxes), and full branding (logo, artwork, private label). This flexibility enables brand owners to launch differentiated products under their own labels while leveraging SENO’s established production infrastructure.

Technical Specifications

The nicotine film (NF-2mg) model features a dissolution time of 10–30 seconds, film size approximately 20mm × 30mm, thickness 50–100 microns, and shelf life of 24 months. Materials include pharmaceutical-grade film-forming polymers, high-purity nicotine, food-grade flavoring agents, and stabilizers. These parameters are customizable per client requirements.

Application / Use-Case Scenarios

A global case study for product 1819 (NF-2mg, Mixed Berries) demonstrates a cooperation period of 1 to 2 years with order quantities ranging from 500,000 to 2,000,000 strips per order. The project achieved stable product performance across batches and strong repeat orders from distributors in Germany, the United States, Australia, the United Arab Emirates, Saudi Arabia, and Canada. Applications include retail distribution, online sales, and private label nicotine product lines, supported by SENO’s OEM/ODM capabilities.

Additional case studies include a Canadian distribution partnership (30 units, 1–2 years) and a French distributor agreement signed after an exhibition, highlighting SENO’s ability to support local market entry through product showcase and consistent supply.

Market Trend Analysis

The nicotine replacement therapy (NRT) category is expanding as regulators and consumers move away from combustible products. Oral films are gaining traction due to their convenience, speed, and discreet profile. Distributors and private-label brands are seeking partners that offer full customization, regulatory compliance (FDA PMTA notification, REACH-compliant Safety Data Sheets), and documented export experience to EU, North America, Australia, and Middle Eastern markets—all areas where SENO has active partnerships.

Comparison with Traditional Solutions

Traditional NRT forms (gum, lozenge, patch) often require longer action times or leave visible residues. SENO’s oral films dissolve in 10–30 seconds and are virtually undetectable after use, offering an advantage in social settings. One honest limitation: oral films may not suit users who prefer a longer-lasting chewing experience, and product storage requires a cool, dry environment to maintain stability.

Future Outlook

With a 20,000 m² production facility, a 15-person R&D team, and annual output capacity ranging from 12 million to 50 million strips, SENO is positioned to support large-scale OEM/ODM projects. Its portfolio of FDA PMTA notifications (certificates PM0010660–PM0010173) and REACH-compliant SDS for multiple flavors (Mint, Strawberry, Blueberry, etc.) signals continued commitment to regulated markets. As global importers seek reliable, compliant manufacturing partners, SENO’s integrated production model and flexible MOQ (100,000–300,000 strips per SKU) provide a pragmatic entry point for testing and scaling.

Frequently Asked Questions (FAQs)

1. What customization options does SENO offer for nicotine oral films?
SENO provides OEM, ODM, and Private Label services, with customization options including nicotine strength (2 mg, 4 mg, 6 mg or custom), flavor development, film size, packaging design, and branding.

2. What certifications does SENO hold for international markets?
SENO holds multiple FDA PMTA notification certificates (e.g., PM0010173, PM0010666) for U.S. distribution, REACH-compliant Safety Data Sheets for EU markets (e.g., DTI2025EC011118-3 for Mint ice), and GS1 China membership for global barcode compliance. The facility is also FDA-registered (FEI: 3038529751).

3. What is the minimum order quantity (MOQ) for OEM orders?
The standard MOQ is 100,000–300,000 strips per SKU, with flexibility for long-term partnerships. Sample confirmation and pre-shipment inspection are included.

4. How does SENO ensure batch consistency and product quality?
SENO implements 100% batch inspection before shipment, raw material verification, in-process quality control, and final product testing with consistency checks.

5. What is the typical lead time for OEM/custom orders?
Standard orders require 20–30 days, while OEM/custom orders take 30–45 days, depending on customization complexity.